IP Library › Granted Patent US 6,841,097
Granted Patent B2
US 6,841,097 · App. 10/148,718 · Granted Jan 11, 2005

Method of producing porous spherical particles

Assignee: Amersham Biosciences AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,841,097
App. No.
10/148,718
Granted
Jan 11, 2005
Kind
B2
Abstract

The invention refers to a method of controlling the porosity of porous spherical particles produced from a polysaccharide dissolved in a solvent, in which it can be gelled. The polysaccharide solution is finely divided by mechanical means into spherical droplets which are allowed to pass through a humid atmosphere and transferred to a capturing medium while controlling the temperature and humidity of humid atmosphere.

Claims (6)

1. In a method of controlling the porosity of porous spherical particles produced from a polysaccharide dissolved in a solvent including water, wherein the polysaccharide solution is finely divided by mechanical means into spherical droplets and transferred to a capturing medium, the improvement comprising conveying said droplets through a humid atmosphere, wherein the temperature and, humidity of said atmosphere are controlled.

2. The method of claim 1 , wherein said temperature and/or said humidity of said atmosphere is set above ambient temperature and/or humidity, and said porosity is retained or increased.

3. The method of claim 2 , wherein the temperature of said capturing medium is brought below that of the gelling temperature of the polysaccharide.

4. The method of claim 1 , wherein said capturing medium comprises water.

5. The method of claim 1 , wherein said polysaccharide is selected from the group comprising agarose, cellulose, starch, and alginate.

6. The method of claim 5 , wherein said polysaccharide is agarose and is dissolved as a 2-14 weight % water solution.

Assignments (4)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2002
From: ANDERSSON, RALF GORAN; JONSSON, INGEMAR
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 013299/0024 →
Priority Claims (1)
SE 9904344 · Dec 1, 1999 · national
Continuity (1)
Related Publication 20030052426A1 · Mar 20, 2003